Aflac (NYSE:AFL – Free Report) had its price target hoisted by Wells Fargo & Company from $116.00 to $124.00 in a research note published on Thursday,Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock.
Other equities analysts also recently issued research reports about the company. Mizuho increased their price target on Aflac from $112.00 to $117.00 and gave the stock an “underperform” rating in a research report on Thursday. Weiss Ratings upgraded Aflac from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Tuesday, November 3rd. Jefferies Financial Group boosted their price objective on Aflac from $108.00 to $112.00 and gave the company a “hold” rating in a research report on Monday, August 10th. JPMorgan Chase & Co. upped their target price on Aflac from $116.00 to $119.00 and gave the stock a “neutral” rating in a research note on Thursday, October 15th. Finally, Raymond James Financial increased their target price on Aflac from $119.00 to $123.00 in a research report on Wednesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $118.73.
Aflac Price Performance
Shares of Aflac stock traded up $0.93 during trading hours on Thursday, reaching $127.44. The stock had a trading volume of 1,750,044 shares, compared to its average volume of 1,671,527. The stock’s 50 day moving average is $118.47 and its 200 day moving average is $116.66. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.30. Aflac has a twelve month low of $105.76 and a twelve month high of $131.18. The firm has a market capitalization of $63.03 billion, a PE ratio of 18.58, a PEG ratio of 1.78 and a beta of 0.55.
Aflac (NYSE:AFL – Get Free Report) last posted its earnings results on Wednesday, November 4th. The financial services provider reported $2.43 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.63. Aflac had a return on equity of 12.82% and a net margin of 21.24%. The firm had revenue of $4.30 billion for the quarter, compared to analysts’ expectations of $4.12 billion. During the same period last year, the firm earned $2.49 EPS. The company’s quarterly revenue was down 31.0% on a year-over-year basis. Equities analysts expect that Aflac will post 7.29 earnings per share for the current fiscal year.
Aflac Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 1st. Investors of record on Wednesday, February 17th will be given a dividend of $0.64 per share. This is a boost from Aflac’s previous quarterly dividend of $0.61. The ex-dividend date is Wednesday, February 17th. This represents a $2.56 annualized dividend and a dividend yield of 2.0%. Aflac’s payout ratio is currently 35.57%.
Insiders Place Their Bets
In related news, major shareholder Post Holdings Co. Ltd. Japan sold 113,611 shares of the firm’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $118.53, for a total value of $13,466,311.83. Following the transaction, the insider directly owned 50,134,329 shares of the company’s stock, valued at approximately $5,942,422,016.37. This trade represents a 0.23% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 699,562 shares of company stock valued at $81,687,749. Company insiders own 0.80% of the company’s stock.
Hedge Funds Weigh In On Aflac
A number of hedge funds have recently made changes to their positions in AFL. Meiji Yasuda Asset Management Co Ltd. purchased a new stake in Aflac in the second quarter valued at approximately $6,630,000. Atlas Wealth LLC acquired a new position in Aflac during the first quarter worth $1,802,000. Callan Family Office LLC acquired a new position in Aflac during the second quarter worth $2,546,000. Tidal Investments LLC boosted its position in shares of Aflac by 137.4% during the second quarter. Tidal Investments LLC now owns 40,904 shares of the financial services provider’s stock worth $4,796,000 after buying an additional 23,677 shares during the period. Finally, Baird Financial Group Inc. boosted its position in shares of Aflac by 12.5% during the second quarter. Baird Financial Group Inc. now owns 341,431 shares of the financial services provider’s stock worth $40,033,000 after buying an additional 37,886 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.
Top Aflac Stories
Investors following AFL have been watching these stories:
- Positive Sentiment: Aflac raised its quarterly dividend 4.9%, from $0.61 to $0.64 per share. The new annualized payout is $2.56 per share, or about a 2.0% yield. Aflac dividend announcement
- Neutral Sentiment: Wells Fargo raised its price target to $124 and JPMorgan to $121 from $119. The higher targets are modestly constructive, though they remain below the recent share price; Wells Fargo maintained an “equal weight” rating. Wells Fargo target update JPMorgan target update
- Neutral Sentiment: Director Joseph Moskowitz sold 600 shares and major shareholder Post Holdings’ Japan entity sold 13,000 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans and were small compared with their remaining holdings.
About Aflac
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
See Also
- Five stocks we like better than Aflac
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
